186 related articles for article (PubMed ID: 12576511)
21. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
Post SM; Groenendijk M; van der Hoogt CC; Fievet C; Luc G; Hoekstra M; Princen HM; Staels B; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2724-30. PubMed ID: 17008588
[TBL] [Abstract][Full Text] [Related]
23. Adipocyte modulation of high-density lipoprotein cholesterol.
Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
[TBL] [Abstract][Full Text] [Related]
24. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo.
Chung S; Sawyer JK; Gebre AK; Maeda N; Parks JS
Circulation; 2011 Oct; 124(15):1663-72. PubMed ID: 21931081
[TBL] [Abstract][Full Text] [Related]
25. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
[TBL] [Abstract][Full Text] [Related]
26. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.
Yue P; Chen Z; Nassir F; Bernal-Mizrachi C; Finck B; Azhar S; Abumrad NA
PLoS One; 2010 Mar; 5(3):e9906. PubMed ID: 20360851
[TBL] [Abstract][Full Text] [Related]
27. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
[TBL] [Abstract][Full Text] [Related]
28. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
[TBL] [Abstract][Full Text] [Related]
29. ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.
Xu B; Gillard BK; Gotto AM; Rosales C; Pownall HJ
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2260-2270. PubMed ID: 29074589
[TBL] [Abstract][Full Text] [Related]
30. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL.
Föger B; Santamarina-Fojo S; Shamburek RD; Parrot CL; Talley GD; Brewer HB
J Biol Chem; 1997 Oct; 272(43):27393-400. PubMed ID: 9341191
[TBL] [Abstract][Full Text] [Related]
31. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.
Chung S; Timmins JM; Duong M; Degirolamo C; Rong S; Sawyer JK; Singaraja RR; Hayden MR; Maeda N; Rudel LL; Shelness GS; Parks JS
J Biol Chem; 2010 Apr; 285(16):12197-209. PubMed ID: 20178985
[TBL] [Abstract][Full Text] [Related]
32. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes.
Maric J; Kiss RS; Franklin V; Marcel YL
J Biol Chem; 2005 Dec; 280(48):39942-9. PubMed ID: 16204232
[TBL] [Abstract][Full Text] [Related]
33. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
[TBL] [Abstract][Full Text] [Related]
35. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
Singaraja RR; Bocher V; James ER; Clee SM; Zhang LH; Leavitt BR; Tan B; Brooks-Wilson A; Kwok A; Bissada N; Yang YZ; Liu G; Tafuri SR; Fievet C; Wellington CL; Staels B; Hayden MR
J Biol Chem; 2001 Sep; 276(36):33969-79. PubMed ID: 11423537
[TBL] [Abstract][Full Text] [Related]
36. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status.
Tamehiro N; Shigemoto-Mogami Y; Kakeya T; Okuhira K; Suzuki K; Sato R; Nagao T; Nishimaki-Mogami T
J Biol Chem; 2007 Jul; 282(29):21090-9. PubMed ID: 17526932
[TBL] [Abstract][Full Text] [Related]
37. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
[TBL] [Abstract][Full Text] [Related]
38. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.
Brunham LR; Kruit JK; Iqbal J; Fievet C; Timmins JM; Pape TD; Coburn BA; Bissada N; Staels B; Groen AK; Hussain MM; Parks JS; Kuipers F; Hayden MR
J Clin Invest; 2006 Apr; 116(4):1052-62. PubMed ID: 16543947
[TBL] [Abstract][Full Text] [Related]
39. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages.
Wang MD; Franklin V; Sundaram M; Kiss RS; Ho K; Gallant M; Marcel YL
J Biol Chem; 2007 Aug; 282(31):22525-33. PubMed ID: 17553802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]